Abstract
Recently, the concept of basal-like carcinoma has been proposed. However, there are only a few reports about the relationship between triple-negative cancer and basal-like carcinoma. In this article, we report the study of the expression of basal cell markers in 11 triple-negative cancers. Eight tumors (4 metaplastic carcinomas, 2 invasive ductal carcinomas, 1 invasive papillary carcinoma, and 1 medullary carcinoma) were positive for more than three markers among cytokeratins 5, 14, and 17, and p63. Three tumors (2 invasive ductal carcinomas and 1 apocrine carcinoma) were completely negative for all markers. Among 8 tumors positive for basal markers, cytokeratins 5 and 17 were expressed in all 8 tumors, cytokeratin 14 in 6 tumors, and p63 in 7 tumors. Finally, we conclude that the majority of triple-negative cancer may correspond to basal-like carcinoma, but the two entities are not identical. The use of combination immunohistochemistry including cytokeratins 5, 14, and 17 and p63 may contribute to the detection of basal-like carcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Foulkes WD, Stefannsson IM, Chappuis PO, Begin LR, Goffin JR, Wong N, Trudel M, Akslen LA (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95:1482–1485
Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET (2003) Breast cancer classification and progenosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 100: 10393–10398
Rakha EA, El-Sayed ME, Reis-Filho JS, Ellis IO (2008) Expression profiling technology: its contribution to our understanding of breast cancer. Histopathology (Oxf) 52:67–81
Payne SJL, Bowen RL, Lones JL, Wells CA (2008) Predictive markers in breast cancer: the present. Histopathology (Oxf) 52: 82–90
Faratian D, Bartlett J (2008) Predictive markers in breast cancer: the future. Histopathology (Oxf) 52:91–98
Jones C, Ford E, Gillett C, Ryder K, Merrett S, Reis-Filho JS, Fulford LG, Hanby A, Lakhani SR (2004) Molecular cytogenetic identification of subgroups of Grade III invasive ductal breast carcinomas with different clinical outcomes. Clin Cancer Res 10: 5988–5997
Arnes JB, Brunet JS, Stefansson I, Begin LR, Wong N, Chappuis PO, Akslen LA, Foulkes WD (2005) Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clin Cancer Res 11:4003–4011
Ribeiro-Silva A, Ramalho LNZ, Garcia SB, Brandao DF, Chahud F, Zucoloto S (2005) p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer. Histopathology (Oxf) 47:458–466
Tsuda H, Morita D, Kimura M, Shinto E, Ohtsuka Y, Matsubara O, Inazawa J, Tamaki K, Mochizuki H, Tamai S, Hiraide H (2005) Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation. Cancer Sci 96:48–53
Leibl S, Gogg-Kammerer M, Sommersacher A, Denk H, Maoinfar F (2005) Metaplastic breast carcinomas: are they of myoepithelial differentiation? Immunohistochemical prolife of the sarcomatoid subtype using novel myoepithelial markers. Am J Surg Pathol 29:347–353
Fulford LG, Easton DF, Reis-Filho JS, Sofronis A, Gillett CE, Lakhan SR, Hanby A (2006) Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology (Oxf) 49:22–34
Shien T, Tashiro T, Omatsu M, Matsuda T, Furuta K, Sato N, Akashi-Tanaka S, Uehara M, Iwamoto E, Kinoshita T, Fukutomi T, Tsuda H, Hasegawa T (2006) Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation. J Clin Pathol 58:1299–1304
Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G (2006) Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her 2/neuoverexpressing phenotypes. Hum Pathol 37:1217–1226
Fadare O, Tavassoli FA (2007) The phenotypic spectrum of basal-like breast cancers: a critical appraisal. Adv Anat Pathol 14: 358–373
Fadare O, Yeh IT (2007) Basal-like breast cancers. Pathol Case Rev 12:143–153
Diaz LK, Cryns VL, Symmans F, Sneige N (2007) Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice. Adv Anat Pathol 14:419–430
Reis-Filho JS, Tutt AN (2008) Triple negative tumours: a critical review. Histopathology (Oxf) 52:108–118
Tavassoli FA, Devilee P (eds) Tumours of the breast and female genital organs. World Health Organization classification of tumours. IARC Press, Lyon, pp 10–80
Kuroda N, Fujishima N, Inoue K, Ohara M, Hirouchi T, Mizuno K, Hayashi Y, Lee GH (2008) Basal-like carcinoma of the breast: further evidence of the possibility that most metaplastic carcinomas may be actually basal-like carcinoma. Med Mol Morphol 41:117–120
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kuroda, N., Ohara, M., Inoue, K. et al. The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma. Med Mol Morphol 42, 128–131 (2009). https://doi.org/10.1007/s00795-008-0428-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00795-008-0428-5